Anupam Rasayan open offer for Bliss GVS Pharma at Rs 299 per share

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

ANURAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.8%1-day move

₹1266.20

prior close

₹1272.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.5-0.4-0.5-0.5-1.8-2.5-3.9———————

Up moveDown movePending

AI summary

Anupam Rasayan India, along with PAC Mates Visa Consultancy, is making a cash open offer to acquire up to 2.77 crore equity shares (26% of expanded voting share capital) of Bliss GVS Pharma at Rs 299 per share. Total consideration is about Rs 829 crore assuming full acceptance. The tender period runs from 28 July to 10 August 2026. The offer is triggered under SEBI takeover rules following a Share Purchase Agreement with existing promoters and certain shareholders of Bliss GVS Pharma.

Likely market impact

Bliss GVS public shareholders get an exit opportunity at Rs 299 per share. Anupam Rasayan is expanding into pharma via acquisition of a listed company.